Tensoflux

Quick links to important sections

Tensoflux

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tensoflux

Quick Facts

Property Description
Active Ingredients Amiloride, Bendroflumethiazide
Form Tablets
Pharmacological Class Antihypertensive, Diuretic
Common Use Management of high blood pressure and edema
Origin Synthetic

What Type of Medicine is Tensoflux?

Tensoflux is classified as a prescription-only medicine that functions as a combination antihypertensive agent and diuretic, designed for oral administration in tablet form. This product is a Fixed-Dose Combination (FDC), pairing two distinct, synthetic active compounds. Pharmacological studies confirm that combining a thiazide-type diuretic with a potassium-sparing diuretic is a clinically recognized therapeutic strategy for improved efficacy in long-term blood pressure management. This FDC structure is designed to offer a more reliable and sustained approach than using either single agent alone.

The medicine's specific classification places it within the group of combined diuretics: a potassium-sparing diuretic paired with a thiazide diuretic. The use of an FDC provides a comprehensive method for managing chronic conditions related to elevated fluid volume and pressure within the circulatory system, which simplifies the patient's regimen.


What is the Composition and General Purpose of Tensoflux?

The composition of Tensoflux includes the two active ingredients: Bendroflumethiazide and Amiloride, which govern its overall therapeutic function. Bendroflumethiazide is the thiazide diuretic component, primarily responsible for promoting the excretion of excess sodium and water through the kidneys.

The inclusion of Amiloride, a potassium-sparing diuretic, serves a crucial protective role; it helps the body retain essential potassium and counteracts the tendency of the thiazide component to cause potassium depletion, thereby maintaining a more stable electrolyte balance. Consequently, the medicine's general purpose is centered on the sustained, controlled reduction of systemic high blood pressure (hypertension) and the relief of swelling, or edema, associated with fluid overload.

What side effects are possible with Tensoflux?

Tensoflux is a combination medicine containing the active ingredients Amiloride and Bendroflumethiazide (often referred to as Hydrochlorothiazide in combination products). Its safety profile is based on the known risks associated with these two diuretic classes, as documented in official drug regulatory texts.

Adverse Reaction Scope

Adverse reactions associated with Amiloride and Bendroflumethiazide affect various organ systems, with the most common and clinically significant events involving the body's electrolytes and fluid balance.

  • Frequency Classification: Side effects are classified in regulatory documents by frequency (e.g., very common, common, uncommon) to indicate the likelihood of occurrence, though precise, official frequency rates for the combination product are often listed in the product label.
  • System-Organ Classes Involved: Adverse effects typically involve the nervous system, gastrointestinal tract, skin, and metabolic and nutritional systems.
  • Serious Adverse Reactions: Clinically significant reactions documented in regulatory sources include severe electrolyte imbalances (e.g., hyperkalemia or hypokalemia), and, less frequently, severe hypersensitivity reactions or blood disorders (like thrombocytopenia).

Safety-Related Considerations and Restrictions

Safety statements in regulatory labels define specific circumstances where the medicine must be used with caution, or is contraindicated, to mitigate risks:

  • Population-Specific Safety Considerations: Caution is often required for patients with pre-existing renal impairment or hepatic impairment (kidney or liver disease) as these conditions can alter how the body processes the medication and increase the risk of serious side effects, particularly electrolyte disturbances.
  • Safety-Related Restrictions or Limitations: The concurrent use of other agents that may affect potassium levels, such as other potassium-sparing diuretics or certain blood pressure medicines, is often a major restriction due to the heightened risk of hyperkalemia (dangerously high blood potassium).

Regulatory Safety Summary

Official regulatory documents structure the safety profile around the primary risk of electrolyte imbalance, detailing which imbalances are common (e.g., hypokalemia from the thiazide component) and which are serious and require specific monitoring (e.g., hyperkalemia from the amiloride component). These classifications provide the framework for understanding the overall risk associated with the medicine.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define Tensoflux overdose primarily by the potential for severe fluid and critical electrolyte imbalances, mandating immediate emergency action. Overdose manifestations may include marked hypotension (low blood pressure), circulatory shock, and signs of central nervous system involvement such as confusion, drowsiness, convulsions, or coma.

Clinical Manifestations and Severe Outcomes

Classification Manifestation Description
Cardiovascular/Electrolyte Potentially fatal Hyperkalemia, severe Hyponatremia, bradycardia, arrhythmias, and profound volume depletion.
Neurological Confusion, drowsiness, seizures, and the risk of Hepatic Encephalopathy in patients with pre-existing severe liver disease.

Required Emergency Actions

Official labeling requires individuals to seek immediate medical attention and contact emergency services at once for any suspected overdose. Treatment is defined as symptomatic and supportive. There is no specific antidote known.

Management procedures, as described in regulatory text, may include the immediate discontinuation of the drug, continuous ECG monitoring to detect cardiac effects from electrolyte shifts, and specific measures (such as intravenous glucose/insulin or sodium bicarbonate) to manage severe Hyperkalemia. Monitoring of vital signs and frequent blood and urine tests for electrolyte levels are required.

Therapeutic Uses of Tensoflux

What Tensoflux Treats: Main Uses and Benefits

The combination of amiloride with a thiazide diuretic is commonly used to help manage high blood pressure and fluid retention associated with conditions like heart failure in situations where low potassium levels are a concern. This medication is commonly used to help manage conditions such as essential hypertension, edema (swelling), and fluid retention associated with Congestive Heart Failure and Liver Disease.

Controlling Sustained High Blood Pressure

Tensoflux may be part of symptomatic management to help address the sustained high pressure of high blood pressure. This primary long-term therapeutic goal directly addresses the symptoms related to elevated pressure against artery walls and contributes to reducing the strain on the cardiovascular system and may assist in managing the overall risk associated with high blood pressure.

“This therapy may be a relevant option when patients require simultaneous volume control and additional support for electrolyte levels.”

Reducing Fluid Overload and Supporting Stability

The combination is considered relevant in managing edema, which is the excess fluid accumulation leading to visible swelling and symptoms related to physical discomfort. It provides necessary symptomatic support to help eliminate this fluid, thereby easing the associated burden and contributing to improved day-to-day comfort and stability. Furthermore, its function helps support stable electrolyte balance and may assist in managing symptoms related to systemic imbalance during long-term management of chronic conditions.


Quick Fact: Relief for Swelling & Pressure
Primary Indication Focus Management of high blood pressure and chronic fluid overload (edema).
Key Symptom Managed Elevated pressure and physical swelling in extremities.
Additional Therapeutic Benefit Assists with maintaining potassium levels during diuretic therapy.

Regulatory References

  1. is commonly used to help manage high blood pressure and fluid retention associated with conditions like heart failure

Eligibility and Restrictions for Use

Tensoflux (Amiloride/Bendroflumethiazide) is officially established for use only in adult patients (ages 18 and over) requiring treatment for conditions like essential hypertension and edema.


Contraindicated Populations

Official regulatory documents stipulate that Tensoflux must not be used in patients with the following absolute contraindications:

  • Pre-existing hyperkalemia (high serum potassium levels).
  • Anuria or severe renal impairment (kidney dysfunction).
  • Severe hepatic impairment (liver dysfunction).
  • Diabetic Nephropathy or symptomatic gout.
  • Known hypersensitivity to either active ingredient or any sulfonamide-derived drug.
  • Receiving potassium supplements or other potassium-sparing diuretics.

Age and Conditional Use

Population Group Regulatory Eligibility Status
Pediatric Patients (Under 18) Use not established; safety and effectiveness are not determined by regulators.
Older Adults (Geriatric) Permitted, but requires close monitoring of kidney function and electrolytes.
Pregnancy/Lactation Contraindicated or Not Recommended; use is advised against unless absolutely essential.

These restrictions define the boundaries of use for Tensoflux, focusing strictly on physiological and disease-state exclusions as mandated by government authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes formally documented interaction patterns for Tensoflux (Amiloride/Bendroflumethiazide), focusing on official restrictions related to blood pressure and electrolyte balance.

Formal Regulatory Restrictions

Classification Interacting Agents
Contraindicated Combinations Lithium (risk of severe toxicity due to reduced clearance); Potassium Supplements/Salts, and Other Potassium-Sparing Diuretics (risk of hyperkalemia).
High-Risk/Avoid Non-Steroidal Anti-Inflammatory Agents (NSAIDs) (may reduce efficacy and increase risk of renal impairment/hyperkalemia); Pimozide or Thioridazine (risk of ventricular arrhythmias due to hypokalemia).

Documented Interaction Outcomes

Co-administration with Angiotensin-Converting Enzyme (ACE) Inhibitors or Angiotensin II Receptor Blockers (ARBs) poses a pharmacodynamic risk, increasing the chance of hyperkalemia and additive hypotensive effects. The hypotensive effect of other antihypertensive medicines, such as Beta-blockers or Calcium Channel Blockers, may be enhanced. The Bendroflumethiazide component may reduce the absorption of the medicine when taken with Cholestyramine or Colestipol. Furthermore, Alcohol ingestion is documented to potentiate the risk of orthostatic hypotension. The risk of cardiotoxicity from Digitalis Glycosides is heightened if the diuretic component causes low potassium levels. Regulatory information notes that in patients with impaired renal function, the risk of toxic reactions, including hyperkalemia, is increased.

Mechanism of Action

How Tensoflux Works

Tensoflux operates by precisely engaging mechanisms within the sympathetic nervous system and related local physiological regulators to induce two primary, non-overlapping effects: changes in peripheral vascular resistance and the relaxation state of certain non-vascular smooth muscle.

Targeting alpha1-Adrenergic Receptors

This domain centers on Tensoflux’s primary role as a selective antagonist that blocks postsynaptic alpha1-adrenergic receptors, particularly the alpha1A subtype. This action interrupts the signaling cascade normally initiated by neurotransmitters like norepinephrine, which regulates vascular tone and peripheral resistance.

Modulating Vascular Smooth Muscle Tone

By inhibiting alpha1-signaling in the peripheral vasculature, Tensoflux prevents the necessary increase in intracellular calcium within the smooth muscle cells. This molecular event leads directly to muscle fiber relaxation (vasodilation), which consequently acts to reduce total peripheral resistance and alters the pressure dynamics within the circulatory system.

Facilitating Relaxation in Genitourinary Tissues

This cluster involves the highly targeted action of Tensoflux on alpha1A receptors located in the prostate and bladder neck. The resulting smooth muscle relaxation in this region helps reduce static outflow obstruction, resulting in an altered resistance to flow in the urogenital tract.

Dosage and Administration Information

How to Use Tensoflux

Tensoflux is an oral Fixed-Dose Combination (FDC) tablet used according to specific administration and dosing protocols.

Feature Description
Route and Form Oral administration only, via tablet.
Dosing Schedule Therapy typically begins with a low dose FDC, such as 5 mg Amiloride combined with 2.5 mg Bendroflumethiazide once daily. The Amiloride component has a labeled maximum daily dose of 20 mg.
Frequency and Timing The medicine is taken once daily in the morning to prevent interference with sleep from diuresis.
Intake Conditions May be administered with or without food.
Missed Dose Rule If the morning dose is missed and not recalled until the late afternoon, the dose must be skipped to avoid nocturnal diuresis.

Dosing requires adjustment for specific groups. Dosage selection for older adults should be cautious and often uses the lower end of the established range. The drug is not recommended for use in patients with severe renal impairment (e.g., creatinine clearance below 25 mL/min). Use for chronic high blood pressure is typically long-term, while maintenance therapy for edema may transition to an intermittent schedule, such as two or three days per week.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tensoflux

The research on Tensoflux, the fixed-dose combination of Amiloride and Bendroflumethiazide, has explored its role in conditions characterized by elevated blood pressure and fluid retention. The evidence available primarily comes from Randomized Controlled Trials (RCTs) and scientific reviews. These studies monitored outcomes related to physiological strain and outcomes related to systemic imbalance in observed populations.


Research Evidence for Managing High Blood Pressure (Hypertension)

The foundation of evidence for Tensoflux in conditions characterized by high blood pressure stems from controlled trials where the combination was evaluated in adults with mild to moderate high blood pressure. Studies monitored patterns observed in the measurements of blood pressure changes. When compared to taking the thiazide diuretic component alone, research has explored the combination’s role in conditions characterized by elevated blood pressure. Evidence from the broader thiazide/amiloride class described patterns in the occurrence of cardiovascular events and the documentation of blood pressure target achievement in studies covering several years.

Research Evidence for Fluid Overload Management (Edema)

The use of Tensoflux for fluid overload, or edema, was studied in conditions involving periods of heightened symptoms of fluid accumulation. Researchers primarily monitored temporary physiological imbalance, measuring changes in body weight and increased urinary output and electrolyte excretion. Studies report how symptoms evolved in the observed populations with fluid retention, indicating the combination was observed in research contexts involving temporary physiological imbalance.

Research on Maintaining Electrolyte Balance

The fixed-dose combination was evaluated in comparative trials to explore short-term symptom changes related to potassium levels. Data show patterns related to the maintenance of potassium levels. Studies report that individuals receiving the combination generally have higher measurements of serum potassium compared to those receiving the thiazide alone. These findings describe patterns observed in the studies, indicating the combination was observed in studies examining potassium conservation during diuretic therapy.


Long-Term Studies and Durability of Response

The available research includes data from efficacy trials with follow-up durations of short or intermediate intervals. Extended-duration data was observed in large-scale outcome trials of the general thiazide/potassium-sparing diuretic class. However, long-term effects on major cardiovascular outcomes are not fully established for the specific Bendroflumethiazide/Amiloride formulation. Therefore, direct evidence on the durability of the observed response over many years is limited.

Key Studies & References

  1. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC) Reports
  2. WHO Model List of Essential Medicines - Classification of Diuretics and Antihypertensive Drugs

Frequently Asked Questions (FAQ)

Common questions about Tensoflux (FAQ)

Q: What is the main difference between Tensoflux and other similar medicines?

A: Official classification describes Tensoflux as a Fixed-Dose Combination (FDC) that contains two distinct diuretics: a thiazide diuretic and a potassium-sparing diuretic. This combination is established in studies to help maintain potassium levels compared to using the thiazide diuretic component alone.

Q: How long does it usually take for Tensoflux to start working?

A: For the management of high blood pressure, a notable reduction is typically observed within two weeks of starting the medicine. According to official product information, the maximum blood pressure-lowering effect is generally achieved after approximately four weeks of consistent use.

Q: How long do the effects of Tensoflux last after taking a dose?

A: The medicine is directed to be taken once daily, which indicates the effects are expected to last throughout the 24-hour dosing interval to maintain consistent control.

Q: Can Tensoflux be used for people who are pregnant?

A: The medicine is generally not recommended or is contraindicated during pregnancy. Regulatory labeling indicates that use is advised against unless the potential benefit is determined to justify the documented potential risks to the fetus, due to documented potential for adverse outcomes associated with the component drugs.

Q: Are there any age restrictions for taking Tensoflux?

A: Use is established for adult patients (18 and over). Safety and effectiveness have not been established for pediatric patients. Older adults are permitted to use the medicine but require close monitoring.

Q: What should I do if my side effects don't go away while taking Tensoflux?

A: Official labeling provides information on adverse reactions, some of which are serious, such as severe electrolyte imbalances. If any reaction is severe or persists, this is a matter referenced in regulatory documents as requiring the knowledge of a healthcare professional.

Q: Is there a generic version of Tensoflux available?

A: Tensoflux is a brand name for a combination of the active ingredients Amiloride and Bendroflumethiazide. The availability of generic versions of the fixed-dose combination depends on regulatory approval and commercial status for that specific product.

Q: Does Tensoflux contain sulfa or gluten?

A: The Bendroflumethiazide component is a sulfonamide-derived drug, which is why official labeling includes a contraindication for patients with hypersensitivity to sulfonamides. Information regarding non-active ingredients, such as gluten content, is located in the official product description section.

Q: How does Tensoflux compare to placebo in clinical trials?

A: Clinical studies, including Randomized Controlled Trials (RCTs), established that the medicine was more effective than a non-medicated control (placebo) in reducing blood pressure and managing fluid overload in the populations studied. This efficacy is the basis for its approved use as described in regulatory documents.

Q: Can older adults use Tensoflux safely?

A: Use in older adults is generally permitted, but regulatory labeling advises caution and often requires close monitoring of kidney function and electrolytes, as this population may be more sensitive to the effects of the medicine.

Q: Can I stop taking Tensoflux once I feel better?

A: The medicine is commonly used for the long-term management of chronic conditions like high blood pressure. Changes to the dosing schedule or discontinuation of therapy are referenced in the Dosage and Administration sections of the prescribing information as matters involving a healthcare professional.

Q: Are the side effects of Tensoflux common or rare?

A: Official labeling classifies adverse reactions by frequency. Most frequently reported reactions, such as headache, dizziness, and gastrointestinal upset, are classified as common. Less frequent but more serious reactions, such as severe electrolyte imbalance, are classified separately and require specific warnings.

Q: Does Tensoflux make you feel tired or drowsy?

A: Common adverse reactions reported in clinical studies include dizziness and fatigue. Less frequent reactions involving the central nervous system may include somnolence (drowsiness) and headache.

Q: Can Tensoflux affect my sleep schedule?

A: The medicine is officially directed to be taken once daily in the morning to help reduce the risk of potential sleep interference from increased urination (diuresis) at night.

Q: Is it normal to have a slight headache when starting Tensoflux?

A: Headache is listed among the adverse reactions reported in clinical studies of the drug and its components. If any reaction is severe or persists, this is a matter referenced in regulatory documents as requiring the knowledge of a healthcare professional.

Q: Does Tensoflux cause stomach upset or nausea?

A: Gastrointestinal reactions such as nausea, vomiting, diarrhea, constipation, and abdominal pain are documented among the adverse reactions in the official labeling.

Q: Is Tensoflux safe for children to use?

A: Safety and effectiveness of Tensoflux in pediatric patients (under 18) have not been established by regulatory authorities. Use is therefore not defined for this population.

Q: Can Tensoflux be taken with common pain relievers like Ibuprofen?

A: The regulatory information notes that Non-Steroidal Anti-Inflammatory Agents (NSAIDs), which includes ibuprofen, may be associated with a potential risk of reduced efficacy of Tensoflux and an increased risk of renal impairment (kidney damage).

Q: Does Tensoflux interact with vitamins or supplements?

A: The medicine is contraindicated with Potassium Supplements or salt substitutes that contain potassium, due to the increased risk of hyperkalemia (high blood potassium). Information regarding interactions with other vitamins or supplements is typically reviewed with a healthcare professional.

Q: Will Tensoflux change the results of my blood tests?

A: Yes. The medicine is documented to alter blood test results, particularly those measuring serum electrolytes (sodium, potassium), blood sugar (glucose), and other markers of kidney function (creatinine, BUN).

Q: Does Tensoflux have a risk of addiction or dependence?

A: Tensoflux is generally not classified as a controlled substance and has no established risk of addiction or dependence, according to official pharmacological classification and regulatory status.

Q: Is Tensoflux a controlled substance?

A: The active ingredients in Tensoflux are not listed as controlled substances under U.S. regulatory classifications.

Q: Can I take Tensoflux with my diabetes medication?

A: Thiazide diuretics, such as a component of Tensoflux, may cause changes in blood glucose tolerance. Official labels state that an adjustment in the dosage of antidiabetic medicines, including insulin, may be required.

Q: Does the research on Tensoflux show long-term use is studied?

A: Research includes long-term data for the general class of thiazide/potassium-sparing diuretics. However, the direct evidence on the durability of the observed response for the specific Tensoflux formulation over many years is limited, as stated in the regulatory research overview.

Q: Is Tensoflux known to cause allergic reactions?

A: Yes. Official warnings note that Tensoflux is contraindicated for patients with known hypersensitivity to the active ingredients or any sulfonamide-derived drug. Allergic reactions, including skin reactions, are among the documented adverse events.

Q: How long can a person safely stay on Tensoflux?

A: Treatment for chronic high blood pressure with Tensoflux is typically considered a long-term therapy. Regulatory documentation outlines the duration of approved use for different indications, such as long-term use for hypertension and intermittent use for edema.

Q: What is the standard frequency of taking Tensoflux?

A: The standard frequency for Tensoflux is generally once daily, taken in the morning. This timing is intended to help reduce the risk of potential sleep interference from increased urination (diuresis) at night.

Q: Can Tensoflux affect my mental health or mood?

A: Yes, adverse reactions affecting the central nervous system and psychiatric health have been reported. These documented effects include depression, insomnia, nervousness, and mental confusion.

Q: Do I need to adjust my diet significantly while taking Tensoflux?

A: Yes. Official warnings advise against the use of potassium-containing salt substitutes or a potassium-rich diet except in specific, monitored circumstances, due to the risk of dangerously high potassium levels (hyperkalemia).

Q: Is it necessary to have certain tests before starting Tensoflux?

A: Yes. Regulatory documentation notes that monitoring of serum electrolytes and kidney function markers (creatinine, BUN) is often necessary before and during therapy to manage risks such as hyperkalemia (dangerously high blood potassium).

Q: What should I know about driving or operating machinery while taking Tensoflux?

A: Warnings are included in the labeling that advise caution with activities requiring mental alertness, such as driving or operating machinery, due to the potential for adverse effects like dizziness or faintness.

Q: Is there a patient information leaflet for Tensoflux online?

A: Yes. The official regulatory prescribing information (e.g., the Summary of Product Characteristics or the DailyMed label) and the patient information leaflet for Tensoflux are published by government authorities and are typically available online.

Q: Are there any warnings about Tensoflux and sun exposure?

A: Yes. Regulatory warnings include a caution that exposure to the sun may cause increased sensitivity (photosensitivity) of the skin in some individuals using the medicine, which may lead to rash or sunburn. This risk is associated with the thiazide diuretic component.

Q: What is the role of the inactive ingredients in Tensoflux?

A: Inactive ingredients are substances included in the tablet formulation that have no therapeutic effect. Their role is to bind the active ingredients, aid in drug delivery, and ensure stability of the medicine.

Q: What is the difference between the different strengths of Tensoflux?

A: The different strengths of Tensoflux are used to allow a healthcare professional to adjust the dose for different phases of treatment, such as starting a low dose for initial therapy or increasing the dose based on monitoring and response, up to the maximum labeled daily dose.

How should Tensoflux be stored and disposed of?

Storage Requirements

Tensoflux (Amiloride/Bendroflumethiazide) tablets must be stored at controlled room temperature, typically maintained below 30 C or within the range of 15 C to 30 C. The medicine must be kept in its original container and the container must remain tightly closed when not in use. Mandatory storage conditions require protection from environmental degradation, specifically guarding the tablets against excessive heat and moisture; therefore, storage in high-humidity areas, such as a bathroom, is prohibited.

Child Safety

Official labeling strictly requires that Tensoflux be stored out of the sight and reach of children.

Disposal Instructions

To comply with environmental protection rules, unused or expired Tensoflux tablets must not be thrown away in household waste or flushed down the toilet. Patients are instructed to return the unused medicine to a pharmacist or follow other local authorized collection schemes for safe disposal in accordance with local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tensoflux found in:

A-Z Index: